EcoDrugPlus

Ensembl ID : ENSMPUG00000002692
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSMPUG00000002683
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSMPUG00000016214
Gene Symbol: -
Cross references: -
109 Possible Orthologues:

Ensembl ID : ENSMPUG00000019395
Gene Symbol: -
Cross references: -
165 Possible Orthologues:

Ensembl ID : ENSMPUG00000019147
Gene Symbol: -
Cross references: -
121 Possible Orthologues:

Ensembl ID : ENSMPUG00000019299
Gene Symbol: -
Cross references: -
127 Possible Orthologues:

Ensembl ID : ENSMPUG00000020127
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSMPUG00000002404
Gene Symbol: -
Cross references: -
56 Possible Orthologues:

Ensembl ID : ENSMPUG00000015081
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSMPUG00000002516
Gene Symbol: -
Cross references: -
94 Possible Orthologues:

Ensembl ID : ENSMPUG00000002510
Gene Symbol: -
Cross references: -
94 Possible Orthologues:

Ensembl ID : ENSMPUG00000013316
Gene Symbol: -
Cross references: -
113 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).